Related Experiment Video
Updated: Jul 13, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
TOR signaling is a determinant of cell survival in response to DNA damage
Changxian Shen1, Cynthia S Lancaster, Bin Shi
1Department of Molecular Pharmacology, St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105, USA.
Abstract:
The conserved TOR (target of rapamycin) kinase is part of a TORC1 complex that regulates cellular responses to environmental stress, such as amino acid starvation and hypoxia. Dysregulation of Akt-TOR signaling has also been linked to the genesis of cancer, and thus, this pathway presents potential targets for cancer chemotherapeutics. Here we report that rapamycin-sensitive TORC1 signaling is required for the S-phase progression and viability of yeast cells in response to genotoxic stress. In the presence of the DNA-damaging agent methyl methanesulfonate (MMS), TOR-dependent cell survival required a functional S-phase checkpoint. Rapamycin inhibition of TORC1 signaling suppressed the Rad53 checkpoint-mediated induction of ribonucleotide reductase subunits Rnr1 and Rnr3, thereby abrogating MMS-induced mutagenesis and enhancing cell lethality. Moreover, cells deleted for RNR3 were hypersensitive to rapamycin plus MMS, providing the first demonstration that Rnr3 contributes to the survival of cells exposed to DNA damage. Our findings support a model whereby TORC1 acts as a survival pathway in response to genotoxic stress by maintaining the deoxynucleoside triphosphate pools necessary for error-prone translesion DNA polymerases. Thus, TOR-dependent cell survival in response to DNA-damaging agents coincides with increased mutation rates, which may contribute to the acquisition of chemotherapeutic drug resistance.
Insights
Target of rapamycin (TOR) kinase regulates cell survival during genotoxic stress. Inhibiting TORC1 signaling in yeast enhances lethality from DNA damage by blocking DNA repair, impacting cancer drug resistance.
Area of Science:
- Cellular Biology
- Molecular Biology
- Genetics
Background:
- The conserved target of rapamycin (TOR) kinase pathway, particularly TORC1, is crucial for cellular responses to environmental stressors like starvation and hypoxia.
- Dysregulation of Akt-TOR signaling is implicated in cancer development, making this pathway a target for chemotherapeutics.
Purpose of the Study:
- To investigate the role of rapamycin-sensitive TORC1 signaling in yeast cell survival and S-phase progression under genotoxic stress.
- To elucidate the mechanism by which TORC1 influences DNA damage response and mutagenesis.
Main Methods:
- Utilized yeast models exposed to the DNA-damaging agent methyl methanesulfonate (MMS).
- Assessed the impact of rapamycin inhibition on TORC1 signaling, S-phase checkpoint activation (Rad53), and ribonucleotide reductase (Rnr1, Rnr3) expression.
- Examined cell viability and mutagenesis rates in wild-type and RNR3-deleted yeast strains.
Main Results:
- Rapamycin-sensitive TORC1 signaling is essential for yeast cell viability and S-phase progression following genotoxic stress.
- TORC1 inhibition suppressed Rad53-mediated induction of Rnr1 and Rnr3, reducing MMS-induced mutagenesis but increasing cell lethality.
- Deletion of RNR3 conferred hypersensitivity to combined rapamycin and MMS treatment, highlighting Rnr3's role in DNA damage survival.
Conclusions:
- TORC1 functions as a survival pathway during genotoxic stress by maintaining deoxynucleoside triphosphate pools for DNA repair polymerases.
- TOR-dependent survival under DNA-damaging conditions correlates with increased mutation rates, potentially contributing to chemotherapeutic resistance.
More Related Videos
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway

